slides · global inventory
Kaplan Meier Survival Analysis
Framework collection for the active corpus filters, with each row opening the slide detail view.
Matching slides 19
Current window 1-19
Pages 1
Rows per page 30
Framework
1-19 of 19
12
Kaplan-Meier survival analysis plot with a risk table below.AstraZeneca | Investor Day Presentation Deck | 34 slides · AstraZeneca
Conference presentation Investor relations Beat · ProductLoop · Cost Of Inaction1 hit
13
Kaplan-Meier survival analysis plot with a risk table at the bottom.AstraZeneca | Investor Day Presentation Deck | 34 slides · AstraZeneca
Conference presentation Investor relations Beat · ProductLoop · Cost Of Inaction1 hit
12
Clinical trial data presentation; includes hazard ratio and median rPFS comparison.AstraZeneca | Investor Day Presentation Deck | 35 slides · AstraZeneca
Conference presentation Investor relations 1 hit
13
The slide uses a Kaplan-Meier plot to visualize time-to-event data for a clinical trial.AstraZeneca | Investor Day Presentation Deck | 35 slides · AstraZeneca
Conference presentation Investor relations 1 hit
22
The slide uses a standard Kaplan-Meier survival analysis framework common in oncology clinical trials.AstraZeneca | Investor Event Presentation Deck | 42 slides · AstraZeneca
Conference presentation Investor relations Beat · Evidence & ProofLoop · Before After1 hit
24
Clinical trial data visualization showing progression-free survival (PFS) curves with associated hazard ratios and event counts.AstraZeneca | Investor Event Presentation Deck | 42 slides · AstraZeneca
Conference presentation Investor relations Beat · Evidence & ProofLoop · Before After1 hit
15
Clinical trial data visualization (Kaplan-Meier plot).AstraZeneca | Investor Event Presentation Deck | 52 slides · AstraZeneca
Conference presentation Investor relations Beat · SatisfactionLoop · Before After1 hit
32
Clinical trial data presentation showing PFS outcomes for Arm 1 (chemo + bev) vs Arm 3 (chemo + bev + durvalumab + olaparib).AstraZeneca | Investor Event Presentation Deck | 52 slides · AstraZeneca
Conference presentation Investor relations Beat · Action1 hit
33
Clinical trial data presentation using Kaplan-Meier plots with associated risk tables and hazard ratios.AstraZeneca | Investor Event Presentation Deck | 52 slides · AstraZeneca
Conference presentation Investor relations Beat · Action1 hit
14
Clinical trial data presented at ASCO GI 2022.Compass Therapeutics | Investor Presentation Deck | 36 slides · Compass Therapeutics
Pitch deck Investor relations Beat · Problem1 hit
18
The slide uses Kaplan-Meier curves to demonstrate clinical efficacy of the platform's drug prioritization.Exscientia | Investor Presentation Deck | 69 slides · Exscientia
Pitch deck Investor relations Beat · Solution (Provide relief)Loop · Golden Circle1 hit
17
Includes Kaplan-Meier survival curves and a clinical decision pathway diagram.Exscientia | Investor Presentation Deck | 73 slides · Exscientia
Pitch deck Investor relations Loop · Cost Of Inaction1 hit
17
Kaplan-Meier survival analysis showing statistically significant improvement in PFS for matched treatments.Exscientia | Investor Presentation Deck | 75 slides · Exscientia
Pitch deck Investor relations Beat · Evidence & Proof1 hit
18
The slide uses Kaplan-Meier curves to demonstrate clinical efficacy of the platform's drug prioritization.Exscientia | Investor Presentation Deck | 76 slides · Exscientia
Pitch deck Investor relations 1 hit
41
The slide uses Kaplan-Meier curves to demonstrate clinical efficacy of the platform's drug prioritization.Exscientia | Investor Presentation Deck | 93 slides · Exscientia
Pitch deck Investor relations Beat · Traction1 hit
18
Includes Kaplan-Meier survival curves and hazard ratios (HR) from a study published in The Lancet Haematology.Exscientia | IPO Presentation Deck | 60 slides · Exscientia
Pitch deck Investment bank Beat · SolutionLoop · Golden Circle1 hit
06
The chart is a classic Kaplan-Meier survival plot used in oncology research.Faeth Therapeutics Series A pitch deck: $47 million to fight cancer · Faeth Therapeutics
Pitch deck Strategy consulting 1 hit
47
Includes Kaplan-Meier survival curves and bioluminescence imaging of tumor activity.Immix Biopharma | Investor Presentation Deck | 60 slides · Immix Biopharma
Pitch deck Investor relations Loop · Golden Circle1 hit
10
The chart shows a clear separation between the treatment and placebo groups, indicating faster viral clearance in the treatment arm.SAB Biotherapeutics | Results Presentation Deck | 12 slides · SAB Biotherapeutics
Regulatory filing Investor relations 1 hit